Release Date: 31/05/13 08:31 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 222.22KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling